Skip to content
Research ReviewExpert reviewedFact-checked July 2026

Vitamin D Dosing: Why Most People Get It Wrong

The mistake isn't the dose — it's dosing to a number instead of a blood level. Here's what the big trials actually showed, the target range that matters, and the two cofactors that decide whether your vitamin D works at all.

Evidence strength

Level 1a

Systematic review of RCTs

Peer-reviewed refs

8

Reading time

9 min

Key Takeaways

  • The big trials (VITAL, DO-HEALTH, D-Health) found no cardiovascular, cancer, or mortality benefit from routine supplementation — because they mostly enrolled people who were already replete. The benefit is in correcting genuine deficiency, not topping up the topped-up.
  • Dose to a blood level, not a pill count. Target a 25(OH)D of 30–50 ng/mL; for most adults without midday sun that's 2000–4000 IU/day of D3. Retest at 8–12 weeks and adjust.
  • Use D3, not D2 — cholecalciferol raises and holds 25(OH)D more effectively than ergocalciferol.
  • Magnesium is the cofactor that activates vitamin D; K2 decides where the absorbed calcium goes. Supplementing D alone ignores both.

The problem with vitamin D advice isn't that the doses are wrong. It's that almost everyone doses to a number — 1000 IU because that's what the bottle says, 5000 IU because a podcast said more is better — when the only thing that matters is the level in your blood. Two people on the same dose can sit at wildly different 25(OH)D values, and the dose that fixes a deficiency does nothing for someone already replete.

That single distinction explains why the headlines about vitamin D keep contradicting each other.

Why the Big Trials "Failed"

Three large randomised trials shaped the current, more sober view:

  • VITAL randomised 25,871 adults to 2000 IU/day and found no reduction in cardiovascular events or invasive cancer over ~5 years. [1]
  • DO-HEALTH gave 2157 older Europeans 2000 IU/day and found no benefit on a composite of blood pressure, infections, falls, fractures, and cognition. [2]
  • The D-Health Trial dosed 21,315 adults with 60,000 IU/month and found no reduction in all-cause mortality. [3]

Read quickly, that looks like vitamin D doesn't work. Read carefully, it says something narrower and more useful: supplementing people who are already replete does little. All three trials enrolled largely vitamin-D-sufficient populations. They were testing "does more help the already-fine?" — and the answer was no.

Where the Benefit Actually Lives

When you look at deficient people, or at specific outcomes, signal appears:

  • VITAL's fracture analysis and a BMJ meta-analysis of individual participant data found the reduction in acute respiratory infections was concentrated in the most deficient participants — those starting below ~25 nmol/L got the clearest benefit. [5]
  • The fracture question is genuinely mixed: a dedicated VITAL analysis found no reduction in fractures in a generally replete population [4] — which again points to the same rule. Correct a deficiency; don't chase benefits by over-topping.

The framing that survives the evidence: vitamin D is a deficiency-correction tool, not a universal enhancer.

Dose to a Level, Not a Pill Count

Here's the practical protocol that follows from all of the above:

  1. Test your 25(OH)D. This is the circulating form and the only way to know where you stand.
  2. Target 30–50 ng/mL (75–125 nmol/L). Comfortably out of deficiency, well short of the range where risk creeps back in.
  3. For most adults without regular midday sun, 2000–4000 IU/day of D3 reaches that range. Bigger bodies need more; deficiency may need a higher short-term correction dose.
  4. Retest at 8–12 weeks and adjust. Then you can settle into a maintenance dose you've actually verified.

Use D3, Not D2

If you're choosing a supplement: cholecalciferol (D3) beats ergocalciferol (D2). A meta-analysis found D3 raises and sustains 25(OH)D more effectively. [6] D2 is mostly a legacy of prescription high-dose products.

The Two Cofactors Almost Everyone Ignores

Vitamin D doesn't act alone, and this is where most stacks fall short:

  • Magnesium is required for every enzymatic step that activates vitamin D. Supplement D while magnesium-deficient and you blunt your own response. [7] Given how common low magnesium intake is, this is not a footnote.
  • Vitamin K2 decides where the newly-absorbed calcium goes. D3 increases calcium absorption; K2 routes it into bone and away from arterial walls. The two are covered together in the K2 article.

This is exactly why the Bone & Arterial Longevity protocol treats D3, K2, and magnesium as one system rather than three separate pills.

Is It Safe at These Doses?

Yes. A systematic review of long-term supplementation at 3200–4000 IU/day found no excess adverse events. [8] Toxicity is real but requires sustained intake far higher than this — hypercalcaemia typically appears only above ~10,000 IU/day maintained for months. The exceptions who should get medical guidance first: sarcoidosis, primary hyperparathyroidism, and a history of calcium kidney stones.

The One-Line Version

Test, target 30–50 ng/mL with 2000–4000 IU of D3, retest, and don't take it without magnesium and K2. That's the whole game — and it's a different game from swallowing a fixed number and hoping.

Related Reading

Scientific References

  1. [1]
    Manson JE, Cook NR, Lee IM, et al.. Vitamin D Supplements and Prevention of Cancer and Cardiovascular DiseaseNew England Journal of Medicine (2019)Oxford 1b
    PMID 30415629
  2. [2]
    Bischoff-Ferrari HA, Vellas B, Rizzoli R, et al.. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical TrialJAMA (2020)Oxford 1b
    PMID 33170239
  3. [3]
    Neale RE, Baxter C, Romero BD, et al.. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortalityLancet Diabetes & Endocrinology (2022)Oxford 1b
    PMID 35026158
  4. [4]
    LeBoff MS, Chou SH, Ratliff KA, et al.. Supplemental Vitamin D and Incident Fractures in Midlife and Older AdultsNew England Journal of Medicine (2022)Oxford 1b
    PMID 35939577
  5. [5]
    Martineau AR, Jolliffe DA, Hooper RL, et al.. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant dataBMJ (2017)Oxford 1a
    PMID 28202713
  6. [6]
    Tripkovic L, Lambert H, Hart K, et al.. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysisAmerican Journal of Clinical Nutrition (2012)Oxford 1a
    PMID 22552031
  7. [7]
    Uwitonze AM, Razzaque MS.. Role of Magnesium in Vitamin D Activation and FunctionJournal of the American Osteopathic Association (2018)Oxford 5
    PMID 29480918
  8. [8]
    Malihi Z, Lawes CMM, Wu Z, et al.. Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trialsEuropean Journal of Nutrition (2023)Oxford 1a
    PMID 36853379
Ad slot available · 728×90Advertise here

Related protocols

Partner with BiohackingHub

Editorial placements, sponsorships, and product features for evidence-minded brands.

Partnership opportunities →